IX-TEND: A Phase IV Observational, Long-Term Follow-Up Study on the Safety and Efficacy of Etranacogene Dezaparvovec in Patients with Hemophilia B
Author(s):
Andreas Tiede, Blanca Salazar, Sean Gill, Paul E. Monahan, Tammuella Chrisentery-Singleton
Publication:
ISTH Congress 2024
Date:
June 22-26, 2024
Topics:
etranacogene dezaparvovec, hemophilia B, ATHN Transcends